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Background: Despite the fact that numerous medications have been introduced to treat renal colic, none has been
proven to relieve the pain rapidly and thoroughly. In this study, we aimed at comparing the effects of intravenous
lidocaine versus intravenous morphine in patients suffering from renal colic.
Methods: In a prospective randomized double-blind clinical trial performed in the emergency department of Imam
Reza educational hospital of Tabriz, Iran, we studied 240 patients, 18–65 years old, who were referred due to renal
colic. Patients were divided into two groups. In group I (120 people) single-dose intravenous lidocaine (1.5 mg/kg)
was administered and in group II (120 people) single-dose intravenous morphine (0.1 mg/kg) was administered
slowly. Visual Analogue Pain Scale (VAS) was recorded while admission, 5, 10, 15 and 30 minutes after injection.
Statistical data and results were studied using descriptive statistics as percentage and Mean ± SD. To compare the
response to treatment, Mann–Whitney U-test was used in two groups. Consequently, the data were analyzed using
the SPSS16 software.
Results: Pain score measured in two groups five minutes after the injection of lidocaine and morphine were 65 %
and 53 % respectively (95% CI 0.60 - 0.69, CI 0.48 – 0.57, p = 0.0002).108 (90 %) patients (95 % CI 0.84 – 0.95) from
group I and 84 (70%) patients (95 % CI 0.62 - 0.78) from group II responded appropriately at the end of the
complete treatment. The difference was statistically significant (p = 0.0001).
Conclusions: Changing the smooth muscle tone and reducing the transmission of afferent sensory pathways,
lidocaine causes a significant reduction in pain.
Trial registration: Clinical Trials IRCT138901042496N3
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Affecting 1-5 % of the population in industrialized coun-
tries, renal colic is considered as a major concern in medi-
cine. Renal colic has been reported to be experienced by
20 % of white males and 5-10 % of white females [1]. The
classic presentation of acute renal colic includes sudden
pain onset radiating from the flank to the lower extremities
which is usually accompanied by microscopic hematuria* Correspondence: soleimanpourh@tbzmed.ac.ir
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distribution, and reproduction in any medium(85 % of cases), nausea and vomiting . Costovertebral angle
tenderness is a common finding as well [2].
To relieve the pain until being discharged or under-
going the required operation is mostly performed in
emergency departments [1]. To achieve this, numerous
medications including antiemetics, narcotics, non-steroidal
anti-inflammatory drugs, antispasmodics, anti-diuretics,
ketorolac, nifedipine, prednisone, acetaminophen and pro-
chlorperazine have been introduces [2].
Lidocaine, being an appropriate choice in treating visceral
and central pain, might also be useful wherever narcotics
are inefficient or lead to undesirable side effects. Intraven-
ous lidocaine is effective in controlling neuropathic painsentral Ltd. This is an Open Access article distributed under the terms of the
creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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herpetic pain, headaches and neurological malignancies
[3,4]. Therefore we aimed at investigating and reviewing
the analgesic effects of intravenous lidocaine compared
with intravenous morphine in patients with renal colic.
Methods
To perform a prospective randomized double-blind clin-
ical trial we evaluated the sample size of 100 people for
each group. This study was approved by Ethics Commit-
tee of “Tabriz University of Medical Sciences”. The trial
was registered in “IRCT”. Additionally, all aspects of the
present study plan were explained to patients and writ-
ten informed consents were obtained consequently.
Considering pain incidence ratios of 29.3 % and 12 % for
the control and intervention groups respectively, confi-
dence interval of 0.05, power of 20 % and loss probability
of 20 % throughout the follow-up period using the follow-
ing formula, a sample size of 100 people were calculated
N ¼ 2 z1 α=2  zβð Þ2  P  1 Pð Þf g= p1 p2ð Þ2
P ¼ p1þ p2ð Þ=2
N ¼ 86þ 15 6¼ 100
As the number of the patients with renal colic refer-
ring to the emergency department of Imam Reza Hos-
pital is abundant [5], the sample size was considered as
120 people for both groups and a total number of 240.
Using the website of www.randomization.com 240 let-
ters of A and B were evenly (120) produced and patients
were allocated to one of the two groups of A (Group I)
and B (Group II), in the order provided by the site.
Patients were evenly divided into two groups of I, receiv-
ing intravenous lidocaine (n= 120), and II, receiving intra-
venous morphine (n= 120). As previously mentioned the
study was double-blind and the executive of the research
project was unaware of the obtained figures using online
software from www.randomization.com. Firstly, patients
entering emergency department with complaint of flank
pain were identified, interviewed and examined. Later,
patients with pain radiating to genitalia and groin, nausea,
vomiting, urinary irritation symptoms and tenderness in
costovertebral angle were selected.
To provide the patients with required analgesia and to
avoid any inconvenience regarding pain management, ini-
tial diagnosis was made based on clinical findings (unilat-
eral abdominal pain radiating to the genitalia) associated
with a positive urine analysis for hematuria. However diag-
nosis was later confirmed using Kidney, Ureter, and Blad-
der (KUB) radiographies and sonography studies. Since all
patients experienced unilateral abdominal pain and their
urine analyses were positive for hematuria, no furtherdiagnostic criteria for renal colic were set throughout the
study [1].
All patients aged 18 to 65 years, and did not have history
of renal, hepatic or cardiac disease (Ischemic Heart
Disease).
Patients with history of allergy to lidocaine and mor-
phine, an inability or unwillingness to provide written
informed consent and pregnant females were excluded
from the study as well. Patients whose pain did not relieve
using lidocaine or morphine were administered supple-
mentary drugs. Then, method of drug administration, the
reason for prescription and possible complications were
explained to the patients and it was emphasized that using
either lidocaine or morphine is safe.
After explaining method of treatment and obtaining
informed written consent, 12 lead electrocardiograms were
taken from all patients to make sure no history of heart
diseases existed. Later, patients were monitored by an
emergency medicine specialist throughout the procedure.
Additionally patients were asked to identify the degree of
their pain using Visual Analogue Pain Scale (VAS), zero
represented painless and 10 was the worst experienced
pain. Vital signs and other symptoms of patients including
nausea, vomiting, dysuria, hematuria, and etc. were
recorded. Firstly, all the enrolled patients received intra-
venous metoclopramide (0.15 mg/kg). Later, to reduce
pain in patients suffering from renal colic in group I lido-
caine solution (1.5 mg/kg) and in group II morphine solu-
tion (0.1 mg/kg) were administered intravenously slowly
(Each syringe contained 10 mL of solution, either 10 mg of
morphine or 200 mg of lidocaine %2 (1 mL=20 mg)). The
trial was considered accomplished when either the patient
had a pain score of less than 3 for 30 minutes after the last
analgesic dose or the 10 mL of solution in the syringe was
used up.
As fluid therapy is not commonly used in our center
to treat patients with renal colic and it is restored only
for patients who are dehydrated or have sepsis, our
patients received very little amount of fluid, (10 mL)
administered only by injection [6].
Notice
All the processes of injection and filling in the question-
naires were performed by another person who was a spe-
cialist (not involved in research project) and blinded to the
injected drug as well as the patients groupings. Patients
were blinded to the injected medications as well. The
doses required for the administered medication were cal-
culated by another colleague. Hence; neither the patients
nor the administrator were aware of the medications used.
Consequently, 5, 10, 15 and 30 minutes after injection,
incidence of pain in patients was recorded based on Visual
Analog Scale (VAS). Statistical data and results were
expressed using descriptive statistics as percentage and
Table 2 Comparison of the mean value of pain reduction
between two groups
Group I Group II P-value
primary VAS 9.65 ± 0.88 9.74 ± 0.63 0.365
VAS5 3.18 ± 2.27 4.45 ± 2.16 0.0001
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tical Mann–Whitney U-test was performed in two groups.
Kolmogroff Smirnov test was used for normality of vari-
ables and QQ plot test was used in cases of necessity. The
data were analyzed using the SPSS16 software.VAS10 1.83 ± 1.59 2.89 ± 2.07 0.0001
VAS15 1.37 ± 1.32 2.55 ± 1.52 0.0001
VAS30 1.13 ± 1.15 2.23 ± 1.57 0.0001Results
Eighty six patients of studied samples were male and
thirty four were female in group I. In group II, ninety
patients were male and thirty were female. There was no
statistically significant difference between them regarding
gender distribution (p = 0.559) (Table 1).
Mean ages of the patients were 35.23±12.37 years and
37.71±11.08 years in group I and II respectively. The differ-
ences was not statistically significant (p=0.104) (Table 1).
There was no statistically significant difference between
mean patient pain scores before drug administration of
two groups (p = 0.365). Pain relief in lidocaine group was
statistically significant compared to the morphine group
(p= 0.0001) (Table 2).
108 patients (90 %) in group I responded to lidocaine
successfully whereas in group II, 84 patients (70 %)
responded properly to morphine, at the end of the study
it was demonstrated that there were more considerable
respond and pain relief in lidocaine group which was sta-
tistically significant (p = 0.0001).
In the present study, patients were also evaluated
regarding having history of kidney stone, renal colic as
(with a history of referring to the hospital or recurrent
stone, and first referral-first stone), side effects (all
recorded side effects in both groups were mild and tem-
porary), stone side and hydronephrosis (Tables 1,3).Discussion
Since renal colic pain caused by urinary stones is severe
and sudden, an appropriate treatment is of great neces-
sity. Narcotics have been considered as main treatmentTable 1 Demographics characteristics of both groups
Group I Group II P-value
Sex Male 71.7 % 28.3 % 0.559
Female 75 % 25 %
age 35.23 ± 12.37 37.71 ± 11.08 0.104
Hydronephrosis left kidney 52 (43.3 %) 52 (43.3 %) 0.684
right kidney 57 (47.5 %) 53 (44.2 %)
did not have
hydronephrosis




Recurrent Stone 49 (41.2 %) 64 (53.3 %) 0.06
First Stone 70 (58.8 %) 56 (46.7 %)
Stone side right kidney 60 (50 %) 57 (47.5 %) 0.698
left kidney 60 (50 %) 63 (52.5 %)of renal colic for years; they relieve pain with central
effects on narcotic receptors. Although narcotics have
adequate effects, there is possibility of their being mis-
used, excessive drowsiness, and other central nervous
system and gastrointestinal complications [7].
Recently, the benefits of non-steroidal anti-inflamma-
tory drugs (NSAIDS) in renal colic have been reported
suggesting them to be more effective compared to nar-
cotic analgesics [8,9].
Renal colic pain is caused by endopelvic pressure and
ureteral obstruction. Increase in renal blood flow follow-
ing obstruction increases urine and endopelvic and ureter
pressure. Prostaglandins cause increase in renal blood
follow and smooth muscle spasm [10].
Nonsteroidal anti-inflammatory drugs, inhibiting cyclo-
oxygenase enzyme, relieve colic pain. Their pain relief
mechanism however differentiates them from narcotic
analgesics. NSAIDs can relieve pain locally and centrally
inhibiting prostaglandin synthesis [11].
In spite of the beneficial effects of nonsteroidal anti-in-
flammatory drugs on pain, NSAIDs can reduce renal blood
flow and ureter pressure in acute ureteral obstruction [12].
Therefore, because in our country (Iran), intravenous
nonsteroidal anti-inflammatory drugs are not available,
we thought of an alternative intravenous drug, i.e. lido-
caine, whose analgesic effects on various pains (post-
operative, cancer and etc.) have been proven [3].
Being an amino amide local anesthetic, Lidocaine blocks
the voltage dependant sodium channels and impulses in
axons [13]. Lidocaine is a relatively safe medication, if used
in low doses. Allergy to this drug however would increase
the risk of cardiac arrhythmia and dyspnea in rare cases.
Most side effects are related to its cumulative effects in-
cluding: perioral numbness, dizziness, confusion, feeling
hangover, and impaired speech [3].
Lidocaine is an effective and cheap drug with few side
effects including dizziness, nausea and constipation. Preva-
lence of these complications however is less with lidocaine
compared to narcotics and other analgesics [14].
On the other hand, side effects of lidocaine are predict-
able with a wide range of confidence. Due to the low half
life, toxicity symptoms of lidocaine are transient and rap-
idly reversible. Based on the results of Rebecca Ferrini’s
study on 100 patients, in most patients having received
Table 3 Percentage of patients reporting side effects
Group I perioral numbness 3 (2.5 %)
transient dizziness 10 (8.3 %)
dysrathria 2 (1.7 %)
Without side effect 105 (87.5 %)
Group II hypotension 3 (2.5 %)
vertigo 2 (1.7 %)
nausea 9 (7.5 %)
vomiting 2 (1.6 %)
Without side effect 104 (86.7 %)
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when the pain was central or visceral, and even when
narcotics were not effective or accompanied unwanted
and unacceptable complications, intravenous lidocaine
could be useful [3].
In the study of Nicky Forov et al. on a pregnant woman
with resistant renal colic, subcutaneous paravertebral
nerve block was performed using lidocaine, in this study
patient’s pain relieved considerably [15]. In our other case
series study, from 8 patients suffering from renal colic re-
sistant to treatment (morphine and NSAIDS), intravenous
lidocaine relieved the pain in 7 patients significantly with
no considerable complications [6].
Other case studies have also been reported regarding
using lidocaine in relieving pain in cancerous and renal colic
patients. In a similar study carried out by Rebecca Ferrini
et al. A single dose of lidocain was administered for redu-
cing pain resistant to morphine in a patient suffering from
primary neuroectodermal tumor. The patient had received
other complementary medicines, in addition to morphine,
such as: gabapentin, baclofen, amitriptyline, clonidine and
clonazepam. Patient’s pain however considerably relieved
after using a single dose of lidocaine (1.5 mg/kg) [3].
The only study which can be compared with ours
regarding considerable pain reduction in short time is a
study carried out by Mansuri Igochi et al. in which local
injection of lidocaine in the most painful point was used
in patients suffering from renal colic (control group
received scopolamine). Considering response to treat-
ment, lidocaine was more effective than scopolamine [12].
Fortunately, in our study no serious or life threatening
complications were observed in patients of lidocaine
group, therefore our study is similar to the study of
Rebecca Ferrini et al.
Lidocaine causes change in sympathetic smooth muscle
tone through reducing the transmission of afferent sensory
pathways. Intravenous lidocaine causes considerable
reduction in pain and can be a suitable alternative for cases
in which narcotics are ineffective or associated with
undesirable complications [16].Conclusion
Our study is unique considering the fact that it is the
first clinical trial study being carried out on using
intravenous lidocaine in patients suffering from renal
colic.
The results of our study revealed that although mor-
phine is used in patients suffering from renal colic as a
drug of choice, due to the rapid response of patients to
lidocaine (considering time and reduction in pain inten-
sity compared to morphine) it can be of great import-
ance in patients with renal colic.
On the other hand, we should note that the complete
response rate to lidocaine treatment was significantly
higher compared to morphine which could be consid-
ered as a reason for lidocaine to be used as a drug of
choice with high priority in patients with renal colic.
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